This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Strunk, K. E. Articles by Muraoka-Cook, R. S. Search for Related Content PubMed PubMed Citation Articles by Strunk, K. E. Articles by Muraoka-Cook, R. S.

HER4 D-Box Sequences Regulate Mitotic Progression and Degradation of the Nuclear HER4 Cleavage Product s80^HER4

¹ UNC Lineberger Comprehensive Cancer Center and the Departments of ² Medicine, ³ Pharmacology, and ⁴ Genetics, University of North Carolina School of Medicine, Chapel Hill, North Carolina

Requests for reprints: Rebecca S. Muraoka-Cook, UNC Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, 102 Mason Farm Road, Chapel Hill, NC 27599. Phone: 919-966-1573; Fax: 919-966-3015; E-mail: rebecca_cook{at}med.unc.edu.

Heregulin-mediated activation of HER4 initiates receptor cleavage (releasing an 80-kDa HER4 intracellular domain, s80^HER4, containing nuclear localization sequences) and results in G₂-M delay by unknown signaling mechanisms. We report herein that s80^HER4 contains a functional cyclin B–like sequence known as a D-box, which targets proteins for degradation by anaphase-promoting complex (APC)/cyclosome, a multisubunit ubiquitin ligase. s80^HER4 ubiquitination and proteasomal degradation occurred during mitosis but not during S phase. Inhibition of an APC subunit (APC2) using short interfering RNA knockdown impaired s80^HER4 degradation. Mutation of the s80^HER4 D-box sequence stabilized s80^HER4 during mitosis, and s80^HER4-dependent growth inhibition via G₂-M delay was significantly greater with the D-box mutant. Polyomavirus middle T antigen–transformed HC11 cells expressing s80^HER4 resulted in smaller, less proliferative, more differentiated tumors in vivo than those expressing kinase-dead s80^HER4 or the empty vector. Cells expressing s80^HER4 with a disrupted D-box did not form tumors, instead forming differentiated ductal structures. These results suggest that cell cycle–dependent degradation of s80^HER4 limits its growth-inhibitory action, and stabilization of s80^HER4 enhances tumor suppression, thus providing a link between HER4-mediated growth inhibition and cell cycle control. [Cancer Res 2007;67(14):6582–90]

This article has been cited by other articles:

				R. S. Muraoka-Cook, M. A. Sandahl, K. E. Strunk, L. C. Miraglia, C. Husted, D. M. Hunter, K. Elenius, L. A. Chodosh, and H. S. Earp III ErbB4 Splice Variants Cyt1 and Cyt2 Differ by 16 Amino Acids and Exert Opposing Effects on the Mammary Epithelium In Vivo Mol. Cell. Biol., September 15, 2009; 29(18): 4935 - 4948. [Abstract] [Full Text] [PDF]

				S.-M. Feng, R. S. Muraoka-Cook, D. Hunter, M. A. Sandahl, L. S. Caskey, K. Miyazawa, A. Atfi, and H. S. Earp III The E3 Ubiquitin Ligase WWP1 Selectively Targets HER4 and Its Proteolytically Derived Signaling Isoforms for Degradation Mol. Cell. Biol., February 1, 2009; 29(3): 892 - 906. [Abstract] [Full Text] [PDF]